why choose us

First received: September 27, 2023

Clinical Trial: Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone

Study Status: Completed

Recruit Status: RECRUITING

Condition: Glaucoma, Open-Angle

Study Type: INTERVENTIONAL


Official Title: Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction With the Placement of iStent Infinite vs. iStent Infinite

Brief Summary: Adult subjects with elevated intraocular pressure who have successfully undergone placement of iStent infinite trabecular bypass system will be randomized to receive a travoprost intraocular implant or receive a sham procedure and be followed for 12 months.

Read more